Cercar
01/01/2024
Initial Treatment with Biological Therapy in Rheumatoid Arthritis
Molina, JT, Hernández-Cruz, B, Corominas, H. Initial Treatment with Biological Therapy in Rheumatoid Arthritis. Journal of Clinical Medicine. 2024; 13(1)DOI:10.3390/jcm13010048. PMID:38202055. IF:2.900(Q1/2D).
01/01/2024
Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia
Clotet-Vidal, S, Prieto, MES, Llorach, PD, Gutiérrez, AS, Pou, JC, Bonafonte, OHT. Malnutrition, Functional Decline, and Institutionalization in Older Adults after Hospital Discharge Following Community-Acquired Pneumonia. Nutrients. 2024; 16(1)DOI:10.3390/nu16010011. PMID:38201841. IF:5.000(Q1/2D).
01/01/2024
A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis
Figueras, I, Feito, M, García-Bustinduy, M, Monte-Boquet, E, Ros, S, Zaragoza, V, De Tena, AL, De Frutos, FJO. A Qualitative Tool to Guide in the Interpretation of the Numerical Rating Scale for Pruritus Intensity in Patients with Atopic Dermatitis. ACTA DERMATO-VENEREOLOGICA. 2024; 104DOI:10.2340/actadv.v104.18255. PMID:38566531. IF:3.700(Q1/2D).
01/01/2024
Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma
Palones E., García-Rivero J.L., Cisneros C., Almonacid-Sánchez C., Pérez-de Llano L., Plaza V., Crespo-Lessmann A.. Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(3)DOI:10.1016/j.arbres.2024.01.002. PMID:38290898. IF:9.200(Q1/1D).
01/01/2024
Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011)
Palones E., Curto E., Pelegrí A., Arilla M., Solanes I., Crespo-Lessmann A.. Archivos de Bronconeumologia 59 (2023) 63–65, (S0300289622004975), (10.1016/j.arbres.2022.07.011). ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.007. PMID:38040573. IF:9.200(Q1/1D).
01/01/2024
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Valverde-Monge M., Sánchez-Carrasco P., Betancor D., Barroso B., Rodrigo-Muñoz J.M., Mahillo-Fernández I., Arismendi E., Bobolea I., Cárdaba B., Cruz M.J., Del Pozo V., Domínguez-Ortega J., González-Barcala F.J., Olaguibel J.M., Luna-Porta J.A., Martínez-Rivera C., Mullol J., Muñoz X., Peleteiro-Pedraza L., Picado Valles C., Plaza V., Quirce S., Rial M.J., Soto-Retes L., Valero A., Sastre J.. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.11.011. PMID:38042707. IF:9.200(Q1/1D).
01/01/2024
Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study
Cano-Jiménez, E, Gómez, AV, Segovia, EV, Barrenechea, MA, Torres, JS, Francesqui, J, Carroz, KP, Solis, AJS, Fernández, OA, González, ABL, Bordas-Martinez, J, Cesar, EC, Vilarnau, EB, Villegas, DC, Pardessus, AR, Fernández, CG, Moyano, MG, Gajate, AU, Hortas, AB, Molina-Molina, M. Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study. Erj Open Research. 2024; 10(1)DOI:10.1183/23120541.00405-2023. PMID:38410707. IF:4.000(Q1/2D).
01/01/2024
Ultrasound in the Study of Thoracic Diseases: Innovative Aspects
Romero, BR, Torrubiano, IV, Juan, JM, Frades, SH, Pallares, JP, Ruiz, VP, Pérez, AW, Ramos, HC, Viedma, EC. Ultrasound in the Study of Thoracic Diseases: Innovative Aspects. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(1)DOI:10.1016/j.arbres.2023.10.009. PMID:37996336. IF:9.200(Q1/1D).